Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure

A simplified neck suction device for activation of carotid baroreceptors.

1975 • 285 citations

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.

1984 • 267 citations

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE

1985 • 186 citations

Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity

1984 • 185 citations

Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition.

1982 • 158 citations

PSITTACOSIS AND SURVEILLANCE

1974 • 133 citations

Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

1984 • 126 citations

Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect.

1985 • 87 citations

Modification of arterial baroreflexes by captopril in essential hypertension

1982 • 81 citations

Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.

1983 • 81 citations

Angiotensin-converting enzyme inhibitor resets baroreceptor reflexes in conscious dogs.

1981 • 63 citations

Clinical and hemodynamic experience with enalapril in congestive heart failure

1985 • 46 citations

ANGIOTENSIN AND THE CARDIAC BAROREFLEX RESPONSE TO PHENYLEPHRINE

1981 • 45 citations

Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.

1984 • 29 citations

Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).

1984 • 23 citations

Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.

1984 • 21 citations

Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.

1984 • 18 citations

Acute and long‐term response to enalapril in congestive failure.

1984 • 11 citations

Enalapril in heart failure.

1984 • 6 citations